Gulf Pharmaceutical Industries P.S.C. (ADX: JULPHAR)

Market Cap	1.06B
Revenue (ttm)	1.66B
Net Income (ttm)	-56.40M
Shares Out	1.16B
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	495,007
Open	0.912
Previous Close	0.912
Day's Range	0.911 - 0.927
52-Week Range	0.701 - 1.410
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 8, 2024

About JULPHAR

Gulf Pharmaceutical Industries P.S.C., together with its subsidiaries, manufactures and sells medicines, drugs, and other pharmaceutical, medical, cosmetic compounds in the United Arab Emirates, other GCC countries, and internationally. It operates through Manufacturing, Plant, Investment, and Others segment. The company provides generic medicines for pain management, GIT and endocrine, antiviral, respiratory, anti-infectives, cardio care, wound care, dermatology, CNS and psychiatry, biotechnology, gynecology women care, anemia, antibiotics, in...

• Industry: Pharmaceutical Preparations
• Founded: 1980
• Employees: 2,400
• Stock Exchange: Abu Dhabi Securities Exchange
• Ticker Symbol: JULPHAR

Financial Performance

In 2023, JULPHAR's revenue was 1.64 billion, an increase of 1.36% compared to the previous year's 1.62 billion. Losses were -99.10 million, 237.1% more than in 2022.